WOOJUNG BIO Inc (215380) - Total Liabilities

Latest as of September 2025: ₩65.22 Billion KRW ≈ $44.20 Million USD

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has total liabilities worth ₩65.22 Billion KRW (≈ $44.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 215380 net assets growth trend to track the company's year-over-year net asset growth rate.

WOOJUNG BIO Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how WOOJUNG BIO Inc's total liabilities have evolved over time, based on quarterly financial data. See WOOJUNG BIO Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

WOOJUNG BIO Inc Competitors by Total Liabilities

The table below lists competitors of WOOJUNG BIO Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Duc Long Gia Lai Group JSC VN:DLG	Vietnam	₫3.22 Trillion
Gurktaler AG ST VI:GAGS	Austria	€568.00K
Avecho Biotechnology Limited F:OEZ	Germany	€5.55 Million
The Steel Public Company Limited BK:THE	Thailand	฿1.80 Billion
rYojbaba Co., Ltd. Common Shares NASDAQ:RYOJ	USA	$1.79 Billion
Flexiroam Ltd AU:FRX	Australia	AU$5.46 Million
Galil Capital Re Spain SOCIMI SA MC:YGCS	Spain	€19.06 Million
Equippp Social Impact Technologies Limited NSE:EQUIPPP	India	Rs168.61 Million

Liability Composition Analysis (2016–2024)

This chart breaks down WOOJUNG BIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 215380 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how WOOJUNG BIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for WOOJUNG BIO Inc (2016–2024)

The table below shows the annual total liabilities of WOOJUNG BIO Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩65.33 Billion ≈ $44.27 Million	-14.45%
2023-12-31	₩76.36 Billion ≈ $51.75 Million	+16.98%
2022-12-31	₩65.28 Billion ≈ $44.24 Million	-4.95%
2021-12-31	₩68.68 Billion ≈ $46.54 Million	+64.36%
2020-12-31	₩41.78 Billion ≈ $28.32 Million	+34.91%
2019-12-31	₩30.97 Billion ≈ $20.99 Million	+31.15%
2018-12-31	₩23.61 Billion ≈ $16.00 Million	+80.62%
2017-12-31	₩13.07 Billion ≈ $8.86 Million	+812.36%
2016-12-31	₩1.43 Billion ≈ $971.15K	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$25.76 Million

₩38.01 Billion KRW

Market Cap Rank

#24236 Global

#1692 in Korea

Share Price

₩2280.00

Change (1 day)

+0.00%

52-Week Range

₩1590.00 - ₩3605.00

All Time High

₩13450.00